BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29183723)

  • 1. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
    Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LINC01138 interacts with PRMT5 to promote SREBP1-mediated lipid desaturation and cell growth in clear cell renal cell carcinoma.
    Zhang X; Wu J; Wu C; Chen W; Lin R; Zhou Y; Huang X
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):337-342. PubMed ID: 30446222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
    Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
    Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma.
    Huang T; Tian W; Zhou Q; Li J; Jiang Z; Chen J; Ge C; Tian H
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):988-996. PubMed ID: 34133712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis identifies NF-κB as a therapeutic target in renal cancer.
    Peri S; Devarajan K; Yang DH; Knudson AG; Balachandran S
    PLoS One; 2013; 8(10):e76746. PubMed ID: 24116146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.
    Ch'ng WC; Abd-Aziz N; Ong MH; Stanbridge EJ; Shafee N
    Cell Oncol (Dordr); 2015 Aug; 38(4):279-88. PubMed ID: 25930675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
    Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
    J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARMA3 Transcriptional Regulation of STMN1 by NF-κB Promotes Renal Cell Carcinoma Proliferation and Invasion.
    Shi D; Zhang Z; Kong C
    Technol Cancer Res Treat; 2021; 20():15330338211027915. PubMed ID: 34190011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
    Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
    Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between vascular endothelial growth factor and nuclear factor-kappaB in renal cell tumors.
    Djordjević G; Matusan-Ilijas K; Sinozić E; Damante G; Fabbro D; Grahovac B; Lucin K; Jonjić N
    Croat Med J; 2008 Oct; 49(5):608-17. PubMed ID: 18925694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATXN3 promotes proliferation, stemness and motility of clear cell renal cell carcinoma cells by regulating S100A8 ubiquitination.
    Bai J; Han J; Fan J; Song J; Wang S
    Physiol Int; 2023 Dec; 110(4):311-325. PubMed ID: 37938238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma.
    Qiu B; Ackerman D; Sanchez DJ; Li B; Ochocki JD; Grazioli A; Bobrovnikova-Marjon E; Diehl JA; Keith B; Simon MC
    Cancer Discov; 2015 Jun; 5(6):652-67. PubMed ID: 25829424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A KLF6-driven transcriptional network links lipid homeostasis and tumour growth in renal carcinoma.
    Syafruddin SE; Rodrigues P; Vojtasova E; Patel SA; Zaini MN; Burge J; Warren AY; Stewart GD; Eisen T; Bihary D; Samarajiwa SA; Vanharanta S
    Nat Commun; 2019 Mar; 10(1):1152. PubMed ID: 30858363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPT2-mediated fatty acid oxidation inhibits tumorigenesis and enhances sorafenib sensitivity via the ROS/PPARγ/NF-κB pathway in clear cell renal cell carcinoma.
    Zeng K; Li Q; Song G; Chen B; Luo M; Miao J; Liu B
    Cell Signal; 2023 Oct; 110():110838. PubMed ID: 37541641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation.
    Gao Y; Nan X; Shi X; Mu X; Liu B; Zhu H; Yao B; Liu X; Yang T; Hu Y; Liu S
    BMC Cancer; 2019 Jul; 19(1):685. PubMed ID: 31299935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc modulates glucose metabolism via regulation of miR-184/PKM2 pathway in clear-cell renal cell carcinoma.
    Huang J; Kong W; Zhang J; Chen Y; Xue W; Liu D; Huang Y
    Int J Oncol; 2016 Oct; 49(4):1569-75. PubMed ID: 27431728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma.
    Cai Z; Luo W; Wang H; Zhu R; Yuan Y; Zhan X; Xie M; Zhuang H; Chen H; Xu Y; Li X; Liu L; Xu G
    Cancer Sci; 2024 Jun; 115(6):1791-1807. PubMed ID: 38480904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.